<HashMap><database>biostudies-literature</database><scores/><additional><submitter>McCready C</submitter><funding>NIAID NIH HHS</funding><funding>Medical Research Council</funding><funding>National Institute for Health Research (NIHR)</funding><funding>NHGRI NIH HHS</funding><funding>Wellcome Trust</funding><pagination>127-135</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9870786</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(2)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Developmental trajectories of childhood wheezing in low-income and middle-income countries (LMICs) have not been well described. We aimed to derive longitudinal wheeze phenotypes from birth to 5 years in a South African birth cohort and compare those with phenotypes derived from a UK cohort.&lt;h4>Methods&lt;/h4>We used data from the Drakenstein Child Health Study (DCHS), a longitudinal birth cohort study in a peri-urban area outside Cape Town, South Africa. Pregnant women (aged ≥18 years) were enrolled during their second trimester at two public health clinics. We followed up children from birth to 5 years to derive six multidimensional indicators of wheezing (including duration, temporal sequencing, persistence, and recurrence) and applied Partition Around Medoids clustering to derive wheeze phenotypes. We compared phenotypes with a UK cohort (the Avon Longitudinal Study of Parents and Children [ALSPAC]). We investigated associations of phenotypes with early-life exposures, including all-cause lower respiratory tract infection (LRTI) and virus-specific LRTI (respiratory syncytial virus, rhinovirus, adenovirus, influenza, and parainfluenza virus) up to age 5 years. We investigated the association of phenotypes with lung function at 6 weeks and 5 years.&lt;h4>Findings&lt;/h4>Between March 5, 2012, and March 31, 2015, we enrolled 1137 mothers and there were 1143 livebirths. Four wheeze phenotypes were identified among 950 children with complete data: never (480 children [50%]), early transient (215 children [23%]), late onset (104 children [11%]), and recurrent (151 children [16%]). Multivariate adjusted analysis indicated that LRTI and respiratory syncytial virus-LRTI, but not other respiratory viruses, were associated with increased risk of recurrent wheeze (odds ratio [OR] 2·79 [95% CI 2·05-3·81] for all LTRIs; OR 2·59 [1·30-5·15] for respiratory syncytial virus-LRTIs). Maternal smoking (1·88 [1·12-3·02]), higher socioeconomic status (2·46 [1·23-4·91]), intimate partner violence (2·01 [1·23-3·29]), and male sex (2·47 [1·50-4·04]) were also associated with recurrent wheeze. LRTI and respiratory syncytial virus-LRTI were also associated with early transient and late onset clusters. Wheezing illness architecture differed between DCHS and ALSPAC; children included in ALSPAC in the early transient cluster wheezed for a longer period before remission and late-onset wheezing started at an older age, and no persistent phenotype was identified in DCHS. At 5 years, airway resistance was higher in children with early or recurrent wheeze compared with children who had never wheezed. Airway resistance increased from 6 weeks to 5 years among children with recurrent wheeze.&lt;h4>Interpretation&lt;/h4>Effective strategies to reduce maternal smoking and psychosocial stressors and new preventive interventions for respiratory syncytial virus are urgently needed to optimise child health in LMICs.&lt;h4>Funding&lt;/h4>UK Medical Research Council; The Bill &amp; Melinda Gates Foundation; National Institutes of Health Human Heredity and Health in Africa; South African Medical Research Council; Wellcome Trust.</pubmed_abstract><journal>The Lancet. Child &amp; adolescent health</journal><pubmed_title>Early childhood wheezing phenotypes and determinants in a South African birth cohort: longitudinal analysis of the Drakenstein Child Health Study.</pubmed_title><pmcid>PMC9870786</pmcid><funding_grant_id>G9815508</funding_grant_id><funding_grant_id>204755/Z/16/Z</funding_grant_id><funding_grant_id>217065/Z/19/Z</funding_grant_id><funding_grant_id>NIHR205037</funding_grant_id><funding_grant_id>U01 AI110466</funding_grant_id><funding_grant_id>U54 HG009824</funding_grant_id><funding_grant_id>MR/S002359/1</funding_grant_id><funding_grant_id>MC_PC_15018</funding_grant_id><funding_grant_id>MC_PC_19009</funding_grant_id><funding_grant_id>204755/z/16/z</funding_grant_id><pubmed_authors>Little F</pubmed_authors><pubmed_authors>Stein DJ</pubmed_authors><pubmed_authors>Custovic A</pubmed_authors><pubmed_authors>Gray DM</pubmed_authors><pubmed_authors>Zar HJ</pubmed_authors><pubmed_authors>Nicol MP</pubmed_authors><pubmed_authors>Haider S</pubmed_authors><pubmed_authors>McCready C</pubmed_authors><pubmed_authors>Workman L</pubmed_authors><pubmed_authors>Granell R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Early childhood wheezing phenotypes and determinants in a South African birth cohort: longitudinal analysis of the Drakenstein Child Health Study.</name><description>&lt;h4>Background&lt;/h4>Developmental trajectories of childhood wheezing in low-income and middle-income countries (LMICs) have not been well described. We aimed to derive longitudinal wheeze phenotypes from birth to 5 years in a South African birth cohort and compare those with phenotypes derived from a UK cohort.&lt;h4>Methods&lt;/h4>We used data from the Drakenstein Child Health Study (DCHS), a longitudinal birth cohort study in a peri-urban area outside Cape Town, South Africa. Pregnant women (aged ≥18 years) were enrolled during their second trimester at two public health clinics. We followed up children from birth to 5 years to derive six multidimensional indicators of wheezing (including duration, temporal sequencing, persistence, and recurrence) and applied Partition Around Medoids clustering to derive wheeze phenotypes. We compared phenotypes with a UK cohort (the Avon Longitudinal Study of Parents and Children [ALSPAC]). We investigated associations of phenotypes with early-life exposures, including all-cause lower respiratory tract infection (LRTI) and virus-specific LRTI (respiratory syncytial virus, rhinovirus, adenovirus, influenza, and parainfluenza virus) up to age 5 years. We investigated the association of phenotypes with lung function at 6 weeks and 5 years.&lt;h4>Findings&lt;/h4>Between March 5, 2012, and March 31, 2015, we enrolled 1137 mothers and there were 1143 livebirths. Four wheeze phenotypes were identified among 950 children with complete data: never (480 children [50%]), early transient (215 children [23%]), late onset (104 children [11%]), and recurrent (151 children [16%]). Multivariate adjusted analysis indicated that LRTI and respiratory syncytial virus-LRTI, but not other respiratory viruses, were associated with increased risk of recurrent wheeze (odds ratio [OR] 2·79 [95% CI 2·05-3·81] for all LTRIs; OR 2·59 [1·30-5·15] for respiratory syncytial virus-LRTIs). Maternal smoking (1·88 [1·12-3·02]), higher socioeconomic status (2·46 [1·23-4·91]), intimate partner violence (2·01 [1·23-3·29]), and male sex (2·47 [1·50-4·04]) were also associated with recurrent wheeze. LRTI and respiratory syncytial virus-LRTI were also associated with early transient and late onset clusters. Wheezing illness architecture differed between DCHS and ALSPAC; children included in ALSPAC in the early transient cluster wheezed for a longer period before remission and late-onset wheezing started at an older age, and no persistent phenotype was identified in DCHS. At 5 years, airway resistance was higher in children with early or recurrent wheeze compared with children who had never wheezed. Airway resistance increased from 6 weeks to 5 years among children with recurrent wheeze.&lt;h4>Interpretation&lt;/h4>Effective strategies to reduce maternal smoking and psychosocial stressors and new preventive interventions for respiratory syncytial virus are urgently needed to optimise child health in LMICs.&lt;h4>Funding&lt;/h4>UK Medical Research Council; The Bill &amp; Melinda Gates Foundation; National Institutes of Health Human Heredity and Health in Africa; South African Medical Research Council; Wellcome Trust.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2026-07-09T12:18:52.365Z</modification><creation>2025-04-05T09:03:15.996Z</creation></dates><accession>S-EPMC9870786</accession><cross_references><pubmed>36435180</pubmed><doi>10.1016/S2352-4642(22)00304-2</doi></cross_references></HashMap>